MARKET

MTNB

MTNB

Matinas Biopharm
AMEX
0.5708
+0.0104
+1.86%
After Hours: 0.5900 +0.0192 +3.36% 18:37 03/26 EDT
OPEN
0.5750
PREV CLOSE
0.5604
HIGH
0.5900
LOW
0.5380
VOLUME
11.02K
TURNOVER
--
52 WEEK HIGH
18.49
52 WEEK LOW
0.4780
MARKET CAP
2.90M
P/E (TTM)
-0.1252
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MTNB last week (0317-0321)?
Weekly Report · 2d ago
Weekly Report: what happened at MTNB last week (0310-0314)?
Weekly Report · 03/17 11:28
Press Release: Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
Dow Jones · 03/11 11:00
Weekly Report: what happened at MTNB last week (0303-0307)?
Weekly Report · 03/10 11:30
Weekly Report: what happened at MTNB last week (0224-0228)?
Weekly Report · 03/03 11:29
Weekly Report: what happened at MTNB last week (0217-0221)?
Weekly Report · 02/24 11:28
Weekly Report: what happened at MTNB last week (0210-0214)?
Weekly Report · 02/17 11:26
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 02/14 12:05
More
About MTNB
Matinas BioPharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology (LNC Platform). Its lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fungal infections. MAT2203 is now positioned for a single, Phase III registration trial (the ORALTO trial) in support of a New Drug Application (NDA) for the treatment of invasive aspergillosis in patients with limited treatment options. It is expanding the utilization of the LNC Platform with small molecules and small oligonucleotides outside of infectious disease, targeting inflammation and oncology. It is also investigating a variety of LNC formulations of two small oligonucleotides designed to target inflammatory cytokines IL-17A and TNFα.

Webull offers Matinas BioPharma Holdings Inc stock information, including AMEX: MTNB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTNB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MTNB stock methods without spending real money on the virtual paper trading platform.